In a precedential opinion, the Federal Circuit on Dec. 7, 2018,
reversed the final determination of the U.S. International Trade
Commission that Laerdal Medical Corp. failed to plead its trade
dress claims with adequate detail, and vacated the ITC’s
decision that no relief was warranted for those claims. The Federal
Circuit remanded the case for the ITC to evaluate public interest
concerns and, if none existed, to issue the appropriate remedy. The
decision demonstrates the value of the ITC for intellectual
property rights holders seeking to combat a wide variety of
intellectual property infringement, particularly in instances where
one or more of the potential respondents may not appear in the ITC
to defend against the infringement claims.